A new prognostic scoring system using factors available preoperatively to predict survival 
Introduction
Perihilar cholangiocarcinoma has one of the poorest prognoses of all cancers. Surgical resection is the only treatment option to cure perihilar cholangiocarcinoma [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . However, mortality and morbidity rates after surgical resection are 0-15% and 14-66%, respectively, which are rather high compared with other cancers. Five-year overall survival rates reported from high-volume centers ranged at 22 to 40% [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . These findings indicate that only selected patients could achieve satisfactory beneficial effects from surgical treatment.
Therefore, it is imperative to establish a judgment standard to select patients who are good candidates for surgical treatment. Although several studies have described prognostic factors and staging systems for classification of biliary cancer, the majority of these factors are only available after surgical resection 1-4, 6-10, 12 , 13 . Many previous reports indicated that nodal metastasis was one of the strongest prognostic factors for survival of perihilar cholangiocarcinoma 8, [14] [15] [16] . However, our previous reports showed that, although nodal metastases are representative poor prognostic factors after surgery for perihilar cholangiocarcinoma, their positive predictive value in preoperative imaging study is quite low 17, 18 . Currently, no staging system using preoperatively available factors exists that can predict survival after surgical resection of perihilar cholangiocarcinoma.
Recently, several reports have indicated that the state of the Systemic Inflammatory Response (SIR) provides significant information about the prognoses of a variety of cancers [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Neutrophil-lymphocyte ratio (NLR), which reflects SIR, has been reported as a prognostic factor in gastrointestinal cancers, including intrahepatic cholangiocarcinoma 19 and colorectal cancer 20 . Platelet-lymphocyte ratio (PLR) has also been described as a prognostic factor for pancreatic cancer 21 . In perihilar cholangiocarcinoma, SIR could be a useful and preoperatively available prognostic factor to select candidates likely to benefit from surgery 34 .
In the present study, we sought to investigate prognostic, clinical, hematological, surgical, and pathological factors of perihilar cholangiocarcinoma, and establish a new staging system using the newly identified and preoperatively available factors to predict survival after major hepatectomy.
Methods

Patients
This study was a retrospective analysis of a prospective database compiled by the Department of Gastroenterological Surgery II at Hokkaido University Hospital. The study protocol received Institutional Review Board approval. All participants provided their written 6 informed consent before treatment. Between July 1999 and October 2009, 131 consecutive patients, who had undergone surgical exploration for perihilar cholangiocarcinoma, were identified from a prospective database maintained by the department. Ten patients did not undergo tumor resection because of peritoneal implantation or extensive vascular involvement. The remaining 121 patients underwent resection with curative intent, resulting in a curative resectability rate of 92.4%, and were included in this study.
Patient's characteristics, operative procedure and operative results in this study were shown in Table 1 . Tumor location was classified according to the Bismuth-Corlette classification 35 .
No definite chemotherapy or radiotherapy was administered before and after surgery. All patients underwent surgical treatment in accordance with the departmental guidelines, which have been reported previously 1 . Using univariate and multivariate analyses, we investigated a wide range of clinical, hematological, surgical, and pathological factors to identify independent prognostic factors that were available preoperatively. In regards to NLR and PLR, univariate and multivariate analysis was performed for 115 patients, because six of one hundred and twenty patients missed preoperative lymphocyte counts. Then, a prognostic scoring system was established using the identified preoperatively available factors. Tumor markers were measured at the time of the preoperative hospital admission.
Complete blood counts and serum CRP level were obtained after biliary drainage when patients were afebrile and without signs of infection such as cholangitis, pneumonia, or urinary tract infection. Where more than one result was available in a factor, the results obtained closest to the date of surgery were used for analysis, on average taken 7 (range, 1-30) days before surgery. Cut-off values for each factor were selected on the basis of the maximum significant differences for survival. Preoperative biliary drainage was performed either at an outside hospital or at our institution.
Operative Procedures
According to the Bismuth-Corlette classification tumor distribution in types I, II, IIIA, IIIB, and IV was 21, 39, 21, 25, and 15 patients, respectively 35 Univariate analysis using preoperative factors showed that serum carcinoembryonic antigen (CEA) levels, CA19-9 levels, albumin levels, CRP levels, PLR, and portal vein embolism were significant clinical prognostic factors. Univariate analysis using histological factors also indicated that T category, N category, perineural invasion, portal vein invasion, and surgical margins were significant prognostic factors ( Table 2) .
Next we performed a multivariate analysis using the six significant preoperative factors and six significant histological factors identified by univariate analysis. Multivariate analysis of the preoperative factors showed that four factors were independent prognostic factors of postoperative survival, as shown in Table 3 : preoperative serum CEA levels >7.0 ng/mL (HR, 5.033; 95% CI: 2.273-11.14; P<0.001), preoperative serum albumin levels <3. 
Association between PLR and Prognostic Factors
Among histopathologic factors, histopathologic grade (G2 or G3), T factor (T3 or T4), and N category had correlation with PLR (Table 4) . Because six patients missed preoperative lymphocyte counts, we performed further investigation on 115 patients.
Preoperative Prognostic Scoring
One point was allocated to each preoperative factor: serum CEA levels>7.0 ng/mL, albumin <3.5 g/dL, CRP >0.5 mg/dL, and PLR >150. The total score was defined as the Preoperative Prognostic Score (PPS) ( Table 5 ). 
Discussion
This study identified four independent factors that can be measured in the preoperative period and that could predict the prognosis of perihilar cholangiocarcinoma. Using a new preoperative scoring system employing PLR and serum CRP and albumin and CEA levels, we were able to predict survival after major hepatectomy and bile duct resection of perihilar cholangiocarcinoma. Additionally, we showed that the score correlated with the histological lymph node status, although the preoperative prediction of nodal metastasis would still be 13 difficult.
Several biomarkers have been used to aid in the diagnosis of cholangiocarcinoma. For perihilar cholangiocarcinoma, Juntermanns et al. reported that the preoperative serum CEA level was correlated with the tumor stage and its unresectability, and could help determine patient prognosis 37 . Some reports have suggested that the serum CEA level is an independent prognostic factor for intrahepatic cholangiocarcinoma [38] [39] [40] . Nevertheless, there are no previous reports indicating that the preoperative serum CEA level serves as an independent prognostic factor for survival.
Recently, many papers reported that SIR (NLR and PLR) is associated with the prognosis for a variety of cancers. In general, SIR reflects a local and systematic chronic inflammation, which could be caused by various types of malignancies. Riesco et al. initially reported the relationships between SIR and blood lymphocyte, monocyte, and platelet counts 22 . The Glasgow prognostic score, reported by Forrest et al. for non-small-cell lung cancer, is widely known as an indicator of SIR 23 . The gastrointestinal cancers also associated with SIR: intrahepatic cholangiocarcinoma, colorectal cancer, liver metastases of colon cancer origin, and hepatocellular cancer 19, 20, [24] [25] [26] 41 . However, only a few reports were available on perihilar cholangiocarcinoma 34, 42 .
The relationship between invasive cancer and SIR is explained as follows: invasive cancer causes tissue damage adjacent to the tumor, resulting in both a local and systemic chronic inflammatory response. Inflammation results in the release of both proinflammatory and inhibitory immunologic mediators. Interleukin (IL)-10 and transforming growth factor-β are the most important inhibitory cytokines, which can cause depressed lymphocyte function and reduced circulating lymphocyte count 27 . Lymphocytopenia is associated with other gastrointestinal malignancies, including colorectal and gastric cancer 28 . Megakaryocyte proliferation is promoted by a number of proinflammatory cytokines, including IL-1, IL-3, and IL-6, which are known to cause thrombocytosis 29, 30 . Increased platelet count is also associated with several other malignancies of the digestive system, including colorectal, gastric, esophageal, and pancreatic cancer [31] [32] [33] . Thrombocytosis and lymphocytopenia both correlate with the degree of host systemic inflammation, and the PLR is a novel marker incorporating both hematologic indices.
The CRP belongs to the family of acute phase proteins. Serum CRP level has also been thought of as a kind of SIR. It is upregulated by cytokines, such as IL-8, IL-6, and tumor necrosis factor α. In vitro studies have identified IL-6 as an autocrine growth factor of cholangiocarcinoma cell lines. In these cells, IL-6 induces the expression of the anti-apoptotic protein Mcl-1 [43] [44] [45] . Moreover, IL-6 was found to be markedly elevated in the serum of patients with cholangiocarcinoma. Remarkably, its levels dropped sharply after resection 46 . Thus, a high CRP level might reflect an increased IL-6 level in patients with advanced cholangiocarcinoma. Increased serum CRP levels are also associated with shorter survival in patients with other malignancies of the digestive system, including perihilar cholangiocarcinoma 47 .
To the best of our knowledge, only two previous reports evaluated NLR in perihilar cholangiocarcinoma 34, 42 . Only one of the previous report identified NLR as an independent prognostic factor for disease-free survival 34 . However, these two reports showed that NLR was not an independent prognostic factor in survival 34, 42 . As far as we know, this report is the first to show that PLR was a significant prognostic factor for survival. The specific reason why PLR and CRP, rather than NLR, were significant prognostic factors of survival was not clear in our study. However, like other gastrointestinal malignancies, SIR would be a significant prognostic factor for perihilar cholangiocarcinoma. Moreover, our data showed that PLR correlated with tumor extent and histopathologic grade in hilar cholangiocarcinoma, suggesting that PLR can reflect the degree of malignancy in this disease. In pancreatic cancer, one previous study reported that preoperative PLR represented a significant independent prognostic index and had prognostic value independent of tumor size and lymph node ratio 8, [14] [15] [16] .
Previous reports have shown that lymph node metastases are the strongest prognostic factors for survival in perihilar cholangiocarcinoma 8, [14] [15] [16] . Predicting the N category in the preoperative period is a very important topic in perihilar cholangiocarcinoma. Our previous reports, however, indicated that it was difficult to diagnose lymph node metastases in biliary cancer by preoperative computed tomography because even the highest positive predictive value was only 67% 17, 18 . Further, our data showed that patients with PPS 0 had satisfactory survival rates. Patients with PPS 0 should be suitable candidates compared with "surgery first" patients. On the other hand, in patients with PPS 3 and 4, it might be that preoperative chemotherapy should be given as first-line treatment, and then curative resection should be reconsidered if there is sufficient future liver remnant and no oncologically apparent contraindication during a set time period. However, there is no evidence about preoperative chemotherapy for perihilar cholangiocarcinoma.
Our scoring system for perihilar cholangiocarcinoma is simple and inexpensive, and thus, it may provide useful information in deciding the operative indications, in particular for highly advanced cases with such as UICC Stage IIIb and IVa/b. However, our study was limited to 121 the consecutive cases performed only in our institute. The evidence level provided by this retrospective analysis is relatively low. Because of the seldom tumor identity, the 10-year period from July 1999 till October 2009 would be quite long. In the future, a multicenter prospective study design to support our hypothesis should be planed.
Conclusion
A new preoperative scoring system employing PLR and serum CRP, albumin, and CEA levels could predict survival after surgical resection of perihilar cholangiocarcinoma. 
